Daniel D Von Hoff, M.D., F.A.C.P.

Physician in Chief and Director of Translational Research at TGen. Chief Scientific Officer for US Oncology and for HonorHealth Clinical Research Institute. Clinical Professor of Medicine, University of Arizona.

Serves on the National Cancer Advisory Board, is editor-in-chief of Molecular Cancer Therapeutics, has served on FDA’s Oncology Advisory Committee, past president of AACR and ASCO’s Board of Directors.